Table 4 Comparison of diagnostic performance between CA19-9 alone and the nomogram model.

From: Development and validation of an easy-to-use nomogram for predicting pancreatic malignancy in patients with pancreatic mass

Model

AUC (95% CI)

DeLong Test

CA19-9

0.869 (0.829–0.910)

Nomogram

0.932 (0.905–0.959)

P < 0.001

  1. CA19-9: carbohydrate antigen 19 − 9; AUC: area under the curve; CI: confidence interval.